Pedro Carrascal, MBA

President, European Multiple Sclerosis Platform (EMSP); Chief Executive Officer, EME (Multiple Sclerosis Spain), Biscay MS Society and MS Basque Foundation Board, Multiple Sclerosis International Federation (MSIF), Bilbao, Spain

Christian-Claus Roth

Global Head Scientific Engagement Governance, Novartis; Co-president, International Pharmaceutical Congress Advisory Association (IPCAA); Member, Ethics and Business Integrity Committee, IFPMA, Basel, Switzerland

Sarah Wheeler, MA

Director of Global Industry Engagement, International Association for the Study of Pain, Washington, DC

Anne-Sophie Bricca, MA, DEA International Law, DES European law

Deputy General Counsel & Senior Director Legal Affairs & Compliance, Terumo BCT, Board Member and Co-chair, Strategic Committee, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Chair, Ethics and Compliance Group MedTech Europe, Brussels, Belgium (Moderator)

Abhiroop Gandhi

Trust and Compliance Officer, Verily Life Sciences (an Alphabet company); Former Vice President, Corporate Compliance, Mallinckrodt San Francisco, CA, USA

Iordanis Kerenidis, PhD

Director, Paris Centre for Quantum Computing (PCQC), CNRS Senior Researcher (DR2), Algorithms and Complexity Group IRIF, University Paris Diderot, Paris, France

Mirgen Jaku, MA

Ethicon EMEA PMO & Digital Surgery Leader, Johnson & Johnson, Hamburg, Germany

Anne-Sophie Bricca

Deputy General Counsel & Senior Director, Legal Affairs & Compliance, Terumo BCT; Board Member and Co-chair, Strategic Committee, International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Chair, Ethics and Compliance Group MedTech Europe, Brussels, Belgium (Discussion Coordinator)

Sofie Melis

Director HR and Ethics & Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland

Julie Bonhomme

Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Aline Lautenberg

General Counsel and Director, Legal & Compliance, MedTech Europe, Brussels, Belgium

Lei Li, LLM

Managing Partner, Beijing and Shanghai Offices, Sidley Austin Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China

Imelda Álvarez, LLB, MBA

Chief Executive Officer, Comply Latam, SC; Former Regional Integrity & Compliance Head Latin America and Canada, Novartis, Mexico City, Mexico

Arthur Muratyan, Esq.

Secretary General, International Society of HealthCare Ethics and Compliance Professionals (ETHICS), Chair, MedTech Compliance Panel; Former VP-Head of Legal Corporate and Global Compliance Officer, Sanofi, Paris, France (Discussion Coordinator)

AFTERNOON MINI SUMMITS

MINI SUMMITS ROUND IV

MINI SUMMIT 14

Best Practices in Virtual Monitoring

1:00 pm CET

Introductions, Panel Discussion and Q&A

Giota Papamarkou

Vice-President, Business Ethics Global, France, Ipsen Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France

Carrie (Ashcom) Pennington, MBA, PhD

Vice President, Global Compliance Monitoring & Internal Controls, Zimmer Biomet; Former Global Compliance Manager, Books & Records, GE Healthcare, Warsaw, IN, USA

Vanessa Westphal, JD, MS

Head of Compliance Center of Excellence Programs & Support, Merck KGaA, Darmstadt, Frankfurt Am Main Area, Germany

Anita Kyung-Hee Kim-Reinartz

Partner, Forensic & Integrity Services, EY Düsseldorf, Germany (Discussion Coordinator)

MINI SUMMIT 15: US DOJ’s Evaluation of Corporate Compliance

1:00 pm CET

Introductions, Panel Discussion and Q&A

Abdul Luheshi, MBA

Independent Consultant, Ethics and Compliance; Former Compliance Officer, International Markets, Myriad Genetics; Former Executive Director, Global Operations, Ethics & Compliance, EMEA, Astellas; London, UK

Sally Molloy, JD

Chief, Strategy, Policy and Training Unit, Fraud Section, US Department of Justice, Washington, DC, USA

Caroline H. West, JD

Former Global Chief Compliance Officer, Olympus Corporation; Former Senior Vice President, Chief Compliance and Risk Officer, Shire, Philadelphia, PA, USA

Amanda N. Raad, JD

Partner and Co-Chair of Global Anti-Corruption and International Risk Practice and R&G Insights Lab, Ropes & Gray, LLP, London, UK (Discussion Coordinator)

MINI SUMMIT 16: Company Principle-based Professional Codes (Not Industry Codes)

1:00 pm CET

Introductions, Panel Discussion and Q&A

Sobia Akram, MSC

Corporate Vice President, Global Business Ethics Compliance Office & Programme, Novo Nordisk A/S, Copenhagen, Capital Region, Denmark

Brett Hudson, MBIM

Global Head Ethics, Risk & Compliance Strategy, Innovation, & Corporate Functions, Novartis; Former Global Program Director Integrity & Compliance, Sandoz, Zurich, Switzerland

Giota Papamarkou

Vice-President, Business Ethics Global, France North America & Global Monitoring, Ipsen; Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France

Pascale Paimbault

President, CEO and Founder, Consulting Alley; Strategic Committee, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Former Executive Director, EMEA Ethics and Compliance, ABAC, Astellas Pharma Europe, Paris, France (Moderator)

MINI SUMMIT 17: Compliance in Clinical Trials and Investigations

1:00 pm CET

Introductions, Panel Discussion and Q&A

Masha Chestukhin, MSJ

Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme; Former Senior Manager NA Compliance, Sanofi; Jamaica Plain, MA, USA

Ana Christian, JD

Senior Director, Assistant General Counsel, Avanir Pharmaceuticals; Former Corporate Counsel, NantHealth,Los Angeles, CA, USA

Stefanie Deronne, JD

Legal Counsel, Argenx; Former Senior Corporate Legal Counsel R&D - DPO, Ablynx; Ghent, Belgium

Genevieve Michaux, JD

Partner, King & Spalding, Brussels, Belgium (Discussion Coordinator)

MINI SUMMITS ROUND V

MINI SUMMIT 18: Annual Middle East Africa (MEA) Compliance Update

2:15 am CET

Introductions, Panel Discussion and Q&A

Ghadeer Al Yacoub, MSc

Regional Head Healthcare Compliance Europe, Middle East and Africa Medical Devices, Johnson & Johnson, Dubai, UAE

Els Janssens, LLM

Counsel, Baker & McKenzie; Former Legal Adviser, European Medicines Agency; Former Senior Legal Counsel, Johnson & Johnson, Brussels, Belgium

Samar Wakim, PharmD

Ethics & Compliance Head MEA, Innovative Medicines, Novartis Pharma Services AG, Dubai, UAE

Joseph W. Henein, PharmD

President and Chief Executive Officer, NewBridge Pharmaceuticals, Dubai, UAE (Co-Discussion Coordinator)

Laura Nassar, PharmD

Vice President, Head of Ethics & Business Integrity, AEME Region, Sanofi; Former Head of Compliance Middle East, Roche Pharmaceuticals; Former Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon (Co-Discussion Coordinator)

MINI SUMMIT 19: Industry's Evolving Role in Medical Education

2:15 pm CET

Introductions, Panel Discussion and Q&A

Holger Diener

Healthcare Compliance Officer, Janssen-Cilag GmbH, Johnson & Johnson; Former Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry (“FSA”), Berlin, Germany

Christian-Claus Roth

Global Head Scientific Engagement Governance, Novartis; Co-president, International Pharmaceutical Congress Advisory Association (IPCAA);Member, Ethics and Business Integrity Committee, IFPMA, Basel, Switzerland

Cerstin Steindorf

Global Account Director Healthcare, MCI, Geneva, Switzerland

Michael Bartke, PhD

Strategic Committee, ETHICS; Former Director Ethics & Compliance, Alexion; Former Director Compliance Management, Daiichi, Sankyo, Europe Munich, Germany (Discussion Coordinator)

MINI SUMMIT 20: EU Whistleblower Directive

2:15 pm CET

Introductions, Panel Discussion and Q&A

Chelsea M. Keeton, JD

Director and Senior Counsel, Global Compliance Investigations, Zimmer Biomet; Former Group Ethics & Compliance Counsel, VEON, Amsterdam, Netherlands

Elisabeth Kohoutek

Senior Associate, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany

Keith Korenchuk, MPH, JD

Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD, USA

Sylvain Mansotte

Co-Founder and Chief Executive Officer, Whispli, Sydney, New South Wales, Australia

Ulf H. Grundmann

Partner, FDA and Life Sciences, King & Spalding LLP, Lecturer, Frankfurt School of Finance and Management, Frankfurt am Main, Germany (Discussion Coordinator)

MINI SUMMIT 21: Global Price Transparent Reporting Update

2:15 pm CET

Introductions, Panel Discussion and Q&A

Brian P. Sharkey

Director, US Commercial Compliance & Ethics, Teva Pharmaceuticals, Parsippany, New Jersey, USA

Sara R. Simon, JD

Associate, Porzio, Bromberg & Newman, PC, Morristown, NJ

John Patrick Oroho, JD

Executive VP & Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio Bromberg & Newman, PC, Morristown, NJ, USA (Discussion Coordinator)

Topic V: Ethics & Compliance in a Third Party Management Beyond Due Diligence

J. Mark Farrar, MSJ, CPA

Managing Director, Compliance Group Leader, Epsilon Life Sciences, Atlanta, GA (Discussion Coordinators)

Gina Nese, JD

Vice President Global Compliance and Ethics Officer, Align Technology; Former Chief Compliance Officer, Advanced Sterilization Products; Bellevue, WA, USA (Discussion Coordinators)

Topic VI: Ethics & Compliance Considerations for Small to Mid-sized Companies

Darren R. Jones

Partner and Leader, Life Sciences Consulting Practice, Baker Tilly, New York, NY

Chrisoula Nikidis, LL.L.

Head of Ethics and Compliance, Takeda Canada; Former Vice President, Ethics, Integrity, & Governance, Innovative Medicines Canada, Toronto, Canada (Discussion Coordinator)

Topic VII: Does the Corporation’s Compliance Program Work in Practice

Jacob T. Elberg, JD

Associate Professor, Seton Hall University School of Law; Former Chief, Health Care & Government Fraud Unit, and Assistant US Attorney, US Attorney's Office, District of New Jersey, Newark, NJ, USA (Discussion Coordinator)

Alex Fell

Head Ethics, Compliance and DPO International, Amicus Therapeutics; Former Vice President, Global Ethics and Compliance, Head of Strategy, Planning and Operations, GSK; London, UK (Discussion Coordinator)

Topic VIII: Ethics and Compliance Lessons Learned from COVID

Brett Hudson, MBIM

Global Head Ethics, Risk & Compliance Strategy, Innovation, & Corporate Functions, Novartis; Former Global Program Director Integrity & Compliance, Sandoz, Zurich, Switzerland (Discussion Coordinator)

Ethan Gumpert

Global Ethics, Compliance & Governance, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA (Discussion Coordinator)